TaiMed Biologics (ROCO:4147) Ending Cash Position : NT$1,863.4 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Ending Cash Position?

TaiMed Biologics's Ending Cash Position for the quarter that ended in Mar. 2024 was NT$1,863.4 Mil.

TaiMed Biologics's quarterly Ending Cash Position declined from Sep. 2023 (NT$265.3 Mil) to Dec. 2023 (NT$251.0 Mil) but then increased from Dec. 2023 (NT$251.0 Mil) to Mar. 2024 (NT$1,863.4 Mil).

TaiMed Biologics's annual Ending Cash Position declined from Dec. 2021 (NT$551.6 Mil) to Dec. 2022 (NT$274.1 Mil) and declined from Dec. 2022 (NT$274.1 Mil) to Dec. 2023 (NT$251.0 Mil).

TaiMed Biologics Ending Cash Position Historical Data

The historical data trend for TaiMed Biologics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Ending Cash Position Chart

TaiMed Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

352.93

572.09

551.62

274.11

251.01

TaiMed Biologics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															225.91	357.18	265.31	251.01	1,863.43

TaiMed Biologics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

TaiMed Biologics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	274.11	+	-23.103
	=	251.0

TaiMed Biologics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	251.007	+	1612.421
	=	1,863.4

TaiMed Biologics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiMed Biologics (ROCO:4147) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492

Website

http://www.taimedbiologics.com

TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines